# Citius Pharmaceuticals, Inc.: filings

CTXR · Nasdaq · CIK 1506251 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ctxr.md) · [Financials](/companies/ctxr/financials.md) · [Filings](/companies/ctxr/filings.md) · [Insiders](/companies/ctxr/insiders.md)

## Reports and events: 298 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 186, 4 112, 10-Q 46, CORRESP 34, UPLOAD 28, 424B3 25, EFFECT 21, S-1/A 19, 424B5 16, 10-K 14, DEF 14A 12, 3 11, S-1 11, DEFA14A 10, SC 13G/A 8, D 7, S-3 7, SC 13G 7, 424B4 4, NT 10-Q 4, PRE 14A 4, S-8 4, 8-K/A 3, ARS 3, NT 10-K 3, POS AM 3, SC 13D/A 3, 10-K/A 2, FWP 2, S-3/A 2, SC 13D 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 10-KT 1, 25-NSE 1, 3/A 1, 425 1, 4/A 1, 8-A12B 1, 8-A12G 1, CERTNAS 1, CT ORDER 1, D/A 1, PRER14A 1, S-3MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:05 ET | [8-K](/filings/0001213900-26-112478.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-112478 |
| 2026-08-21 | 16:15 ET | [8-K](/filings/0001213900-26-092604.md) | 3.01 Delisting notice | 0001213900-26-092604 |
| 2026-08-14 | 16:35 ET | [10-Q](/filings/0001213900-26-090185.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090185 |
| 2026-08-14 | 16:35 ET | [8-K](/filings/0001213900-26-090181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090181 |
| 2026-08-05 | 09:27 ET | [8-K](/filings/0001213900-26-085432.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-085432 |
| 2026-06-01 | 16:30 ET | [8-K](/filings/0001213900-26-063531.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-063531 |
| 2026-05-15 | 16:41 ET | [8-K](/filings/0001213900-26-057876.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-057876 |
| 2026-05-15 | 16:31 ET | [10-Q](/filings/0001213900-26-057842.md) | Quarterly report, period 2026-03-31 | 0001213900-26-057842 |
| 2026-05-08 | 16:30 ET | [8-K](/filings/0001213900-26-053916.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-053916 |
| 2026-04-29 | 16:30 ET | [8-K](/filings/0001213900-26-049338.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-049338 |
| 2026-04-24 | 17:00 ET | [8-K](/filings/0001213900-26-047599.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-047599 |
| 2026-04-06 | 16:15 ET | [8-K](/filings/0001213900-26-040474.md) | 5.07 Shareholder vote results | 0001213900-26-040474 |
| 2026-03-31 | 16:32 ET | [8-K](/filings/0001213900-26-037524.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037524 |
| 2026-03-10 | 09:03 ET | [8-K](/filings/0001213900-26-025459.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-025459 |
| 2026-03-04 | 09:25 ET | [8-K](/filings/0001213900-26-023439.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-023439 |
| 2026-02-24 | 08:00 ET | [DEF 14A](/filings/0001213900-26-019566.md) | Proxy statement, period 2026-04-06 | 0001213900-26-019566 |
| 2026-02-13 | 08:30 ET | [8-K](/filings/0001213900-26-015895.md) | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-015895 |
| 2026-02-13 | 08:00 ET | [10-Q](/filings/0001213900-26-015878.md) | Quarterly report, period 2025-12-31 | 0001213900-26-015878 |
| 2026-01-28 | 16:30 ET | [10-K/A](/filings/0001213900-26-008861.md) | Annual report, amended, period 2025-09-30 | 0001213900-26-008861 |
| 2025-12-23 | 16:49 ET | [8-K](/filings/0001213900-25-125413.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-125413 |
| 2025-12-23 | 16:21 ET | [10-K](/filings/0001213900-25-125333.md) | Annual report, period 2025-09-30 | 0001213900-25-125333 |
| 2025-12-01 | 17:03 ET | [8-K](/filings/0001213900-25-116760.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116760 |
| 2025-10-23 | 17:12 ET | [8-K](/filings/0001213900-25-101741.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-101741 |
| 2025-10-21 | 16:41 ET | [8-K](/filings/0001213900-25-100847.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-100847 |
| 2025-08-12 | 16:51 ET | [8-K](/filings/0001213900-25-075034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-075034 |
| 2025-08-12 | 16:31 ET | [10-Q](/filings/0001213900-25-074997.md) | Quarterly report, period 2025-06-30 | 0001213900-25-074997 |
| 2025-07-08 | 17:00 ET | [8-K](/filings/0001213900-25-062099.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-062099 |
| 2025-06-12 | 08:45 ET | [8-K](/filings/0001213900-25-053607.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053607 |
| 2025-06-09 | 17:29 ET | [8-K](/filings/0001213900-25-052718.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-052718 |
| 2025-06-03 | 16:30 ET | [8-K](/filings/0001213900-25-050822.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-050822 |
| 2025-05-30 | 17:15 ET | [8-K](/filings/0001213900-25-049550.md) | 3.01 Delisting notice | 0001213900-25-049550 |
| 2025-05-14 | 16:30 ET | [10-Q](/filings/0001213900-25-043360.md) | Quarterly report, period 2025-03-31 | 0001213900-25-043360 |
| 2025-05-14 | 16:30 ET | [8-K](/filings/0001213900-25-043362.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043362 |
| 2025-04-28 | 07:30 ET | [DEF 14A](/filings/0001213900-25-035755.md) | Proxy statement, period 2025-06-09 | 0001213900-25-035755 |
| 2025-04-18 | 16:05 ET | [8-K](/filings/0001213900-25-033366.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-033366 |
| 2025-04-03 | 16:15 ET | [8-K](/filings/0001213900-25-028622.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-028622 |
| 2025-04-02 | 16:05 ET | [8-K](/filings/0001213900-25-028003.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-028003 |
| 2025-03-10 | 16:30 ET | [8-K](/filings/0001213900-25-022237.md) | 5.07 Shareholder vote results | 0001213900-25-022237 |
| 2025-02-14 | 16:47 ET | [8-K](/filings/0001213900-25-014359.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-014359 |
| 2025-02-14 | 16:30 ET | [10-Q](/filings/0001213900-25-014321.md) | Quarterly report, period 2024-12-31 | 0001213900-25-014321 |
| 2025-02-06 | 09:20 ET | [8-K](/filings/0001213900-25-010747.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010747 |
| 2025-01-27 | 16:13 ET | [10-K/A](/filings/0001213900-25-006997.md) | Annual report, amended, period 2024-09-30 | 0001213900-25-006997 |
| 2025-01-27 | 16:05 ET | [DEF 14A](/filings/0001213900-25-006984.md) | Proxy statement, period 2025-03-10 | 0001213900-25-006984 |
| 2025-01-08 | 16:05 ET | [8-K](/filings/0001213900-25-002071.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-002071 |
| 2025-01-07 | 09:11 ET | [8-K](/filings/0001213900-25-001408.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-001408 |
| 2024-12-27 | 17:10 ET | [8-K](/filings/0001213900-24-113158.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-113158 |
| 2024-12-27 | 17:00 ET | [10-K](/filings/0001213900-24-113149.md) | Annual report, period 2024-09-30 | 0001213900-24-113149 |
| 2024-12-20 | 16:30 ET | [8-K](/filings/0001213900-24-111212.md) | 8.01 Other events | 0001213900-24-111212 |
| 2024-11-27 | 16:05 ET | [SC 13D/A](/filings/0001213900-24-103453.md) | Ownership report, active investor, amended | 0001213900-24-103453 |
| 2024-11-26 | 16:15 ET | [8-K](/filings/0001213900-24-102833.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-102833 |

Page 1 of 6. [Older](/companies/ctxr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.